Record Date for Determination of Shareholders

Notice of Record Date for Determination of Shareholders Opposing the Small-Scale Merger with A-STIN Co., Ltd.

In accordance with Article 354, Paragraph 4 of the Korean Commercial Act, SCAI Therapeutics Co., Ltd. hereby announces that the following record date has been set to determine shareholders who may express their objection to the proposed small-scale merger with A-STIN Co., Ltd.

○ Record Date for Determination of Shareholders: November 13, 2024

October 29, 2024

SCAI Therapeutics Co., Ltd.
21, Gangnam-daero 107-gil, Seocho-gu, Seoul, Korea
Chief Executive Officer: Chul hwan Kim